Why the study?
The study was conducted to investigate the distribution of triggers in PAF patients and assess the efficacy of CPVI combined with non-PV trigger ablation over 1 year.
Does a standardized pre-CPVI induction protocol combined with CPVI and non-PV trigger ablation improve 1-year freedom from atrial arrhythmia recurrence in patients with paroxysmal atrial fibrillation?
Does a standardized pre-CPVI induction protocol combined with CPVI and non-PV trigger ablation improve 1-year freedom from atrial arrhythmia recurrence in patients with paroxysmal atrial fibrillation?
Pre-CPVI drug and high-frequency atrial stimulation reveals a high prevalence of non-PV triggers (particularly in the SVC), and their targeted ablation is independently associated with reduced 1-year AF recurrence.
Answers are grounded in this paper and cite their sources.
May support adjunctive non-PV trigger ablation in paroxysmal AF; hypothesis-generating and requires randomized confirmation before practice change.
OBJECTIVE: Investigate the distribution of triggers in paroxysmal atrial fibrillation (PAF) patients and assess the efficacy of circumferential pulmonary vein isolationI (CPVI) combined with non-pulmonary veins (PV) trigger ablation over 1 year. METHODS: This prospective study included 130 PAF patients undergoing initial catheter ablation. A standardized protocol was applied before CPVI, followed by ablation targeting non-PV triggers. Ablation success was marked by the inability to induce atrial fibrillation (AF) or related arrhythmias. Patients underwent Holter monitoring at intervals post-surgery, culminating in a 7-day exam at 12 months. RESULTS: Atrial fibrillation (AF) was induced in 88 patients (67.0%), with 94 foci identified. The left pulmonary vein was a common source, but the superior vena cava emerged as the most prevalent non-PV site. The 1-year success rate was 86.0%, with no significant differences in success rates among trigger types. However, non-PV triggers were linked to lower recurrence rates post-surgery (HR 0.27, 95% CI 0.08-0.96, p = 0.04). CONCLUSION: The study found that the combination of drug stimulation and high-frequency atrial stimulation before CPVI significantly boosted AF induction rates and revealed a high incidence of non-PV triggers. Effective intraoperative induction and accurate identification of non-PV triggers, particularly in the superior vein cava (SVC), contributed to a substantial reduction in postoperative recurrence rates. This approach suggests a potential strategy for improving outcomes in PAF treatment.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: